ReviewCells2023

KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions.

Nastaran Karimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.